RNA drug developer ADARx seeks $1.74 billion valuation in US IPO

Technology By Reuters • September 21, 2026, 1:40 PM UTC
⏱ 1 min read 👁 3 views
Direct Source Verification: This story is aggregated from Reuters (reuters.com). Full reporting rights and copyright belong to the primary publisher.
Read on Reuters ↗
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO  Reuters
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO  Reuters
Original Source
https://www.reuters.com/business/healthcare-pharmaceuticals/adarx-pharmaceuticals-targets-174-billion-valuation-us-ipo-2026-09-21/
Visit Reuters ↗
SHARE STORY:
𝕏 f in

Related Coverage in Technology